# SNC116 Therapy for Refractory Systemic Lupus Erythematosus

> **NCT07748156** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 28 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** SNC116

## Key facts

- **NCT ID:** NCT07748156
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748156, "SNC116 Therapy for Refractory Systemic Lupus Erythematosus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*